Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$21.87 - $28.24 $743 - $960
-34 Reduced 1.04%
3,246 $84,000
Q1 2024

Apr 18, 2024

BUY
$27.21 - $39.48 $7,509 - $10,896
276 Added 9.19%
3,280 $93,000
Q4 2023

Jan 25, 2024

SELL
$21.2 - $31.03 $62,794 - $91,910
-2,962 Reduced 49.65%
3,004 $91,000
Q3 2023

Oct 27, 2023

BUY
$26.2 - $36.08 $156,309 - $215,253
5,966 New
5,966 $160,000
Q2 2023

Jul 18, 2023

SELL
$25.16 - $41.38 $17,259 - $28,386
-686 Reduced 8.75%
7,153 $255,000
Q1 2023

Apr 13, 2023

BUY
$23.68 - $38.51 $41,866 - $68,085
1,768 Added 29.12%
7,839 $199,000
Q4 2022

Jan 23, 2023

SELL
$28.0 - $40.56 $2,408 - $3,488
-86 Reduced 1.4%
6,071 $0
Q3 2022

Oct 26, 2022

SELL
$29.63 - $48.31 $5,718 - $9,323
-193 Reduced 3.04%
6,157 $203,000
Q2 2022

Jul 25, 2022

SELL
$27.79 - $50.61 $1.03 Million - $1.87 Million
-37,017 Reduced 85.36%
6,350 $223,000
Q1 2022

May 02, 2022

BUY
$39.62 - $69.97 $112,283 - $198,294
2,834 Added 6.99%
43,367 $1.99 Million
Q4 2021

Jan 28, 2022

BUY
$58.09 - $82.51 $2.35 Million - $3.34 Million
40,533 New
40,533 $2.69 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.